Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-201 Juvenile Batten Disease Gene Therapy … – Nasdaq
Weekly Register |
Abeona Therapeutics Receives FDA Orphan Drug Designation for ABO-201 Juvenile Batten Disease Gene Therapy …
Nasdaq NEW YORK and CLEVELAND, June 29, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare diseases, announced … Is Abeona Therapeutics Incorporated (NASDAQ:ABEO)'s Fuel Running Low? Reports Show More Sellers |
